NewAmsterdam Pharma Correlations

NAMSW Stock

9.69 0.16 1.68%

The current 90-days correlation between NewAmsterdam Pharma and Ikena Oncology is 0.09 (i.e., Significant diversification). The correlation of NewAmsterdam Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

NewAmsterdam Pharma Correlation With Market

Average diversification

The correlation between NewAmsterdam Pharma and DJI is 0.15 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and DJI in the same portfolio, assuming nothing else is changed.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NewAmsterdam Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more information on how to buy NewAmsterdam Stock please use our How to Invest in NewAmsterdam Pharma guide.

Moving together with NewAmsterdam Stock

0.78	BMY	Bristol Myers Squibb Aggressive Push	Pair Corr
0.97	NAMS	NewAmsterdam Pharma	Pair Corr
0.69	PMVP	Pmv Pharmaceuticals	Pair Corr
0.71	AGIO	Agios Pharm	Pair Corr
0.84	SGMO	Sangamo Therapeutics Buyout Trend	Pair Corr
0.8	AVTE	Aerovate Therapeutics	Pair Corr
0.75	CRVS	Corvus Pharmaceuticals	Pair Corr
0.64	VREX	Varex Imaging Corp	Pair Corr

Moving against NewAmsterdam Stock

0.85	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.8	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.8	PEPG	PepGen	Pair Corr
0.74	NKTX	Nkarta Inc Buyout Trend	Pair Corr
0.63	FDMT	4D Molecular Therapeutics	Pair Corr
0.47	MREO	Mereo BioPharma Group	Pair Corr
0.47	PIRS	Pieris Pharmaceuticals	Pair Corr
0.43	PDSB	PDS Biotechnology Corp	Pair Corr
0.37	IVVD	Invivyd	Pair Corr
0.34	RGNX	Regenxbio	Pair Corr
0.75	COLL	Collegium Pharmaceutical	Pair Corr
0.68	ADAP	Adaptimmune Therapeutics	Pair Corr
0.63	BDTX	Black Diamond Therap	Pair Corr
0.6	ANEB	Anebulo Pharmaceuticals	Pair Corr
0.52	SYBX	Synlogic	Pair Corr
0.47	TCBPW	TC BioPharm plc	Pair Corr

Related Correlations Analysis

	IKNA	ELYM	HCWB	RNXT	TPST	SCPH	MIST	MCRB	LUMO
IKNA		-0.29	-0.31	0.12	-0.13	-0.21	0.27	-0.28	0.33	IKNA
ELYM	-0.29		-0.01	-0.32	0.79	0.9	-0.57	0.76	-0.72	ELYM
HCWB	-0.31	-0.01		0.24	-0.19	-0.15	0.09	0.12	-0.03	HCWB
RNXT	0.12	-0.32	0.24		-0.37	-0.39	0.72	0.03	0.29	RNXT
TPST	-0.13	0.79	-0.19	-0.37		0.74	-0.51	0.58	-0.78	TPST
SCPH	-0.21	0.9	-0.15	-0.39	0.74		-0.57	0.67	-0.58	SCPH
MIST	0.27	-0.57	0.09	0.72	-0.51	-0.57		-0.34	0.53	MIST
MCRB	-0.28	0.76	0.12	0.03	0.58	0.67	-0.34		-0.61	MCRB
LUMO	0.33	-0.72	-0.03	0.29	-0.78	-0.58	0.53	-0.61		LUMO
	IKNA	ELYM	HCWB	RNXT	TPST	SCPH	MIST	MCRB	LUMO

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

SCPH	+ 0.9	ELYM
TPST	+ 0.79	ELYM
MCRB	+ 0.76	ELYM
SCPH	+ 0.74	TPST
MIST	+ 0.72	RNXT
MCRB	+ 0.67	SCPH

High negative correlations

LUMO	- 0.78	TPST
LUMO	- 0.72	ELYM
LUMO	- 0.61	MCRB
LUMO	- 0.58	SCPH
MIST	- 0.57	SCPH
MIST	- 0.57	ELYM

Risk-Adjusted Indicators

There is a big difference between NewAmsterdam Stock performing well and NewAmsterdam Pharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze NewAmsterdam Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
IKNA	0.90	(0.11)	0.00	(0.09)	0.00	0.00	1.80	(1.74)	5.87
ELYM	3.87	(0.92)	0.00	(2.63)	0.00	0.00	6.21	(9.35)	34.87
HCWB	13.10	3.70	0.32	(0.97)	8.25	(22.68)	22.00	(16.67)	352.85
RNXT	3.47	0.47	0.09	1.00	3.88	(4.63)	7.55	(6.20)	40.06
TPST	3.90	(0.60)	0.00	(0.58)	0.00	0.00	6.38	(8.53)	29.55
SCPH	2.76	(0.63)	0.00	(0.24)	0.00	0.00	4.30	(7.09)	20.70
MIST	1.85	0.22	0.13	0.26	1.57	(2.76)	7.19	(2.11)	18.66
MCRB	4.93	0.32	0.04	1.12	5.57	(5.97)	10.84	(9.78)	28.84
LUMO	2.35	0.27	0.03	(0.28)	2.95	(2.63)	5.95	(5.19)	16.25

NewAmsterdam Pharma Corporate Management

Louise Kooij	Treasurer, CFO	Profile
Jim Jacobson	Chief Secretary	Profile
Annie Neild	VP Affairs	Profile
FESC MD	Chief Founder	Profile
Marc MD	Chief Officer	Profile
MSc MBA	Chief Officer	Profile
Lina Gugucheva	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC